Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine in Dementia with Lewy Bodies
NCT00230997Phase 3Completed
- Sponsor
- Neurological Research Center
- Start
- Dec 2002
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of galantamine in dementia with Lewy bodies (DLB), sponsored by Neurological Research Center. Started Dec 2002; status: completed.
02
Drugs
galantamine
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT00230997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230997.